5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide

C26H24BrCl2N3O3 — CID 147338913

IUPAC5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide
SMILESC=CC(=O)N1CC(CC(=O)Cn2cc(C(=O)NCCc3ccc(Cl)cc3Cl)c3cc(Br)ccc32)C1
InChIInChI=1S/C26H24BrCl2N3O3/c1-2-25(34)32-12-16(13-32)9-20(33)14-31-15-22(21-10-18(27)4-6-24(21)31)26(35)30-8-7-17-3-5-19(28)11-23(17)29/h2-6,10-11,15-16H,1,7-9,12-14H2,(H,30,35)
InChIKeyDDCDBXMGQCKLID-UHFFFAOYSA-N
MW577.31 g/mol
LogP5.29
Rot. Bonds9

About 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide

5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide (PubChem CID 147338913) has the molecular formula C26H24BrCl2N3O3 and a molecular weight of 577.31 g/mol. Its IUPAC name is 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide.

Molecular Properties

Compound Name5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide
PubChem CID147338913
Molecular FormulaC26H24BrCl2N3O3
Molecular Weight577.31 g/mol
Exact Mass575.04
IUPAC Name5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide
SMILESC=CC(=O)N1CC(CC(=O)Cn2cc(C(=O)NCCc3ccc(Cl)cc3Cl)c3cc(Br)ccc32)C1
InChIInChI=1S/C26H24BrCl2N3O3/c1-2-25(34)32-12-16(13-32)9-20(33)14-31-15-22(21-10-18(27)4-6-24(21)31)26(35)30-8-7-17-3-5-19(28)11-23(17)29/h2-6,10-11,15-16H,1,7-9,12-14H2,(H,30,35)
InChIKeyDDCDBXMGQCKLID-UHFFFAOYSA-N
XLogP5.29
TPSA71.41 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms35
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500577.31
LogP ≤ 55.29
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide?
The IUPAC name of 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide (CID 147338913) is 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide.
What is the SMILES notation for 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide?
The canonical SMILES for 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide is C=CC(=O)N1CC(CC(=O)Cn2cc(C(=O)NCCc3ccc(Cl)cc3Cl)c3cc(Br)ccc32)C1.
What is the InChIKey of 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide?
The InChIKey is DDCDBXMGQCKLID-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H24BrCl2N3O3/c1-2-25(34)32-12-16(13-32)9-20(33)14-31-15-22(21-10-18(27)4-6-24(21)31)26(35)30-8-7-17-3-5-19(28)11-23(17)29/h2-6,10-11,15-16H,1,7-9,12-14H2,(H,30,35).
What are the key properties of 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide?
5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide has a molecular weight of 577.31 g/mol, XLogP of 5.29, 9 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-N-[2-(2,4-dichlorophenyl)ethyl]-1-[2-oxo-3-(1-prop-2-enoylazetidin-3-yl)propyl]indole-3-carboxamide is sourced from PubChem (CID 147338913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).